COc1cccc(/C=C2\S/C(=N/Nc3nc(-c4ccc([N+](=O)[O-])cc4)cs3)NC2=O)c1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?